Ronald Miller
Cardiovascular Disease · Farmington Hills, MINPI 1164405536
Payments from drug & device makers
What this record shows
This record is dominated by other: $12,849 of the $16,869 with a category attached, or 76.2%. Cardio Flow, Inc. accounts for 76.2% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $12,849, 6.5 times the $1,979 reported in 2019.
Across 92 payments — averaging $183.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardio Flow, Inc.$13K
- Abbott$934
- Amgen$643
- Novartis$384
- Medtronic$216
- Heartflow, Inc.$162
- plus $2K from 25 others
What the payments were for
- Grants$550%
- Food & beverage$3,80223%
- Education$190%
- Entertainment$1431%
- Other$12,84976%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardio Flow, Inc. | 1 | $12,849 |
| Abbott | 8 | $934 |
| Amgen | 13 | $643 |
| Novartis | 16 | $384 |
| Medtronic | 2 | $216 |
| Heartflow, Inc. | 2 | $162 |
| Philips North America LLC | 2 | $159 |
| Boehringer Ingelheim | 3 | $155 |
| Sanofi | 1 | $150 |
| Impulse Dynamics (USA) Inc. | 1 | $140 |
| E.r. Squibb & Sons, L.L.C. | 2 | $137 |
| Abiomed | 1 | $130 |
| Edwards Lifesciences | 5 | $127 |
| Sanofi-aventis U.S. LLC | 2 | $126 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $70 |
| Merck | 4 | $64 |
| Actelion Pharmaceuticals US, Inc. | 3 | $61 |
| Johnson & Johnson | 3 | $56 |
| Boston Scientific | 1 | $55 |
| AstraZeneca | 3 | $52 |
| Chiesi USA, Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Penumbra, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Infobionic, Inc | 1 | $16 |
| CMP Pharma, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $15 |
| United Therapeutics Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$362
- OPTIMIZER$279
- Accent Pacemaker$279
- ENTRESTO$223
- IN.PACT Admiral$216
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$154
- FABRAZYME$150
- Confirm Rx$144
- Unify Assura CRT Defibrillator$144
- Impella$130
- CAMZYOS$125
- JARDIANCE$125
- PRALUENT$119
- AMPLATZER AMULET$115
- (5027) Intact Vascular Undivided$111
How this compares
$16,869 in reported general payments places this provider in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $262 |
| Lisinopril | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Farmington Hills
- George DiraniFarmington Hills$70K
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.